Subscribe To

Price Alert Latest News Economic Calendar News

BIOL / BIOLASE to Participate in the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 in New York

LAKE FOREST, Calif. , Nov. 14, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the 11th Annual Benchmark Discovery One-on-One Investor Conference taking place December 1, 2022 in New York City. Read More

Demo Live Account See Partner Details

Content Topics

Biolase

Participate

Benchmark

Discovery

One

On

Investor

One on one

Conference

December

Stock

BIOL

Posted: Nov 14 2022, 06:30

Author Name: PRNewsWire

BIOL News

By InvestorPlace
May 12, 2023

Why Is Biolase (BIOL) Stock Down 13% Today?

Biolase (NASDAQ: BIOL ) stock is taking a beating on Friday following the release of its earnings report for the first quarter of 2023. The bad news

By Seeking Alpha
March 28, 2023

BIOLASE, Inc. (BIOL) Q4 2022 Earnings Call Transcript

BIOLASE, Inc. (NASDAQ:BIOL ) Q4 2022 Earnings Conference Call March 28, 2023 4:30 PM ET Company Participants Todd Kehrli - IR John Beaver - President

By PRNewsWire
March 13, 2023

BIOLASE TO REPORT FOURTH QUARTER AND FULL YEAR 2022 RESULTS ON MARCH 28, 2023

LAKE FOREST, Calif. , March 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will r

By PRNewsWire
February 16, 2023

BIOLASE TO PRESENT AT THE THIRD ANNUAL WINTER WONDERLAND BEST IDEAS VIRTUAL INVESTOR CONFERENCE

LAKE FOREST, Calif. , Feb. 16, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has bee

By PRNewsWire
November 14, 2022

BIOLASE to Participate in the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 in New York

LAKE FOREST, Calif. , Nov. 14, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invi

By Seeking Alpha
November 10, 2022

BIOLASE, Inc. (BIOL) Q3 2022 Earnings Call Transcript

BIOLASE, Inc. (NASDAQ:BIOL ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Todd Kehrli - Investor Relations John

By PRNewsWire
June 2, 2022

BIOLASE TO PRESENT AT LD MICRO INVITATIONAL INVESTOR CONFERENCE ON JUNE 8, 2022

LAKE FOREST, Calif. , June 2, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it will be p

By Seeking Alpha
March 17, 2022

BIOLASE, Inc. (BIOL) CEO John Beaver on Q4 2021 Results - Earnings Call Transcript

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.